Article
Successful treatment of Japanese hemophilia patient co-infected with HIV and HCV genotype 4a by glecaprevir/pibrentasvir therapy.
Clinical journal of gastroenterology - 1 Dec 2021
Sato Ken, Kanayama Yuki, Yamazaki Yuichi, Tojima Hiroki, Suga Takayoshi, Uehara Daisuke, Kakizaki Satoru, Yanagisawa Kunio, Uraoka Toshio, Ohnishi Hiroshi, Okamoto Hiroaki
Abstract excerpt
Although direct-acting antiviral (DAA)-based anti-hepatitis C virus (HCV) therapies are very effective for patients with genotypes 1 and 2, evidence of the efficacy of DAA-based therapy for the special population of patients with genotypes 3-6 is insufficient due to the relatively small number of these subjects in Japan. Human immunodeficiency virus (HIV)/HCV-co-infected patients are recommended to be treated as...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.